Cargando…

An incentive-based approach may be the only approach to achieve COVID-19 herd immunity

Detalles Bibliográficos
Autor principal:	Fradkin, C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Masson SAS. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8188382/ https://www.ncbi.nlm.nih.gov/pubmed/34124327 http://dx.doi.org/10.1016/j.jemep.2021.100686

Ejemplares similares

COVID-19 vaccination and herd immunity In Africa: An incentive-based approach could be the game-changer to vaccine hesitancy
por: Onigbinde, Oluwanisola Akanji, et al.
Publicado: (2022)

Achieving Population Immunity Against the COVID-19 Threat
por: Fradkin, Chris
Publicado: (2022)

Will achieving herd immunity be a road to success to end the COVID-19 pandemic?
por: KWOK, Kin On, et al.
Publicado: (2021)

COVID-19, Herd Immunity and Vaccine
por: Tin, Sim Sai, et al.
Publicado: (2023)

COVID-19 natural herd immunity and risk of neuropsychiatric disorders
por: Losilla-Rodríguez, Beatriz, et al.
Publicado: (2020)

Can India develop herd immunity against COVID-19?
por: Gowrisankar, A., et al.
Publicado: (2020)

COVID-19 natural herd immunity and risk of neuropsychiatric disorders
por: Losilla-Rodríguez, Beatriz, et al.
Publicado: (2020)

Timeliness and obsolescence of herd immunity threshold estimates in the COVID-19 pandemic
por: Gomes, M.G.M.
Publicado: (2022)

Herd immunity against COVID-19: is it enough to stop a second wave?
por: AbdAllah, M., et al.
Publicado: (2020)

Herd immunity: Deadly or defensive
por: Khan, Sameena, et al.
Publicado: (2021)

How Long that a SARS-CoV-2 Variant Delay Impacts Required Period to Achieve Herd Immunity?
por: Joob, Beuy, et al.
Publicado: (2023)

Can Thailand achieve COVID‐19 herd immunity?
por: Jitanan, Manatee, et al.
Publicado: (2022)

COVID-19: Is herd immunity the only option for fragile Yemen?
por: Noushad, Mohammed, et al.
Publicado: (2021)

A herd immunity approach to the COVID-19 pandemic?
por: Takefuji, Yoshiyasu
Publicado: (2022)

Change Paradigm in the Face of COVID-19; From Bans to Incentives
por: Jabbari, Alireza, et al.
Publicado: (2021)

COVID-19 pandemic: An incentive for medical curricular reform in Iraq
por: Al-Mendalawi, Mahmood D.
Publicado: (2022)

Exhaustion or fatigability may not only be cardiac but also myopathic
por: Finsterer, J., et al.
Publicado: (2015)

COVID-19 vaccine uptake in the US is hampered by mistrust from Black and Latinx communities
por: Fradkin, C.
Publicado: (2022)

May interferon λ be a novel therapeutic approach against COVID-19?
por: Roohi, Azam, et al.
Publicado: (2021)

Why many African countries may not achieve the 2022 COVID-19 vaccination coverage target
por: Idris, Israel Oluwaseyidayo, et al.
Publicado: (2022)

Challenges that may impact achieving and maintaining accreditation in clinical laboratories in Zambia during the COVID-19 pandemic
por: Daka, Victor, et al.
Publicado: (2021)

Can Africa achieve herd immunity?
por: Lucero-Prisno, Don Eliseo, et al.
Publicado: (2021)

Achieving herd immunity in South America
por: Lucero-Prisno, Don Eliseo, et al.
Publicado: (2023)

Vaccination Is the Only Acceptable Path to Herd Immunity
por: Rasmussen, Angela L.
Publicado: (2020)

Herd immunity threshold for SARS-CoV-2 and vaccination effectiveness in Brazil
por: Siqueira, Priscila C., et al.
Publicado: (2022)

Perspectives on the Zika outbreak: herd immunity, antibody-dependent enhancement and vaccine
por: Silva, José Valter Joaquim, et al.
Publicado: (2017)

COVID-19 herd immunity in the absence of a vaccine: an irresponsible approach
por: Khalife, Jade, et al.
Publicado: (2021)

Response to “Moghnieh et al. COVID-19: Second Wave or Multiple Peaks, Natural Herd Immunity or Vaccine – We Should be Prepared”
por: Khalid, Dua, et al.
Publicado: (2020)

Lockdown—the only solution to defeat COVID-19
por: Gupta, Abhishek, et al.
Publicado: (2020)

COVID-19 Vaccine Superstations as a Model to Rapidly Achieve Herd Immunity
por: Keehner, Jocelyn, et al.
Publicado: (2021)

Road to achieving COVID‐19 herd immunity in Niger Republic: Challenges and recommendations
por: Abdou, Sil‐Ana Salissou, et al.
Publicado: (2022)

Dilative arteriopathy in Pompe disease may not only affect the cerebral arteries
por: Finsterer, Josef
Publicado: (2018)

Development of Herd Immunity to COVID-19 in Louisiana Nursing Homes
por: Reilly, Thomas A.
Publicado: (2021)

Toward Achieving a Vaccine-Derived Herd Immunity Threshold for COVID-19 in the U.S.
por: Gumel, Abba B., et al.
Publicado: (2021)

COVID-19 herd immunity by immunisation: are children in the herd?
por: Obaro, Stephen
Publicado: (2021)

COVID-19 and anticoagulant based therapeutics: Approach with great promise
por: Sharma, Varun Kumar, et al.
Publicado: (2021)

Not only pulmonary rehabilitation for critically ill patients with COVID-19
por: Estraneo, Anna, et al.
Publicado: (2020)

Money for a vaccine? Pay incentives as a solution to increase vaccination rates during the COVID-19 pandemic
por: Haman, M., et al.
Publicado: (2022)

Response to: Does Combined Anterior-Posterior Approach Improve Outcomes Compared with Posterior-only Approach in Traumatic Thoracolumbar Burst Fractures?: A Systematic Review
por: O’Donohoe, Tom, et al.
Publicado: (2020)

Herd immunity for COVID-19
por: Burki, Talha Khan
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6jtap013toh2o432sujmrnve4v